check out GILD, its the AAL of biotech........beat estimates, add $12 bil buy back, up div and barely up after getting killed, lowest p/e for that large of company in bio.......seems like market wants potential...not actual earnings
I'm tempted to buy more of we see 35, but it's got to be that low before I jump in. I always get nervous when I see analysts say there's little potential downside. Ha.